Science Explorer Back to mapMap
Discussion
Researcher · Abbott Fund · United States

Evelyn Mary McKeegan

Evelyn Mary McKeegan publishes mostly in Molecular Biology, Oncology and Pulmonary and Respiratory Medicine, on topics such as Angiogenesis and VEGF in Cancer, PARP inhibition in cancer therapy and Lung Cancer Treatments and Mutations.

OpenAlex
World rank
#1,022,319
of 7,710,434 ranked researchers
Rank in United States
#333,032
of 1,627,098
Works
63
Citations
4.5k
Citations per work
71.6
h-index
23
i10-index 31Top 26% in Molecular Biology

What does Evelyn Mary McKeegan research?

Evelyn Mary McKeegan's work is mostly in Medicine (49%), Biochemistry, Genetics and Molecular Biology (27%).

Life Sciences27%Health Sciences49%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3149.1%
    1. Biochemistry, Genetics and Molecular Biology1727.3%
  1. Everything else1523.6%
  1. 1Molecular Biology22% of their works
  2. 2Oncology20% of their works
  3. 3Pulmonary and Respiratory Medicine12% of their works
  4. 4Hematology10% of their works
  5. 5Genetics8% of their works
  6. 6Cancer Research6% of their works

Research topics

Which keywords describe Evelyn Mary McKeegan's research?

The keywords of their largest research topics: Prognostic Factors, Clinical Trials, Targeted Therapy, Cancer Therapy, Cell Death, Immunotherapy, endothelial progenitor cells and VEGF.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 22 words, with their numbers
  1. Prognostic Factors203 topics
  2. Clinical Trials172 topics
  3. Targeted Therapy172 topics
  4. Cancer Therapy152 topics
  5. Cell Death152 topics
  6. Immunotherapy142 topics
  7. VEGF101 topic
  8. endothelial progenitor cells101 topic
  9. ALK Inhibitors91 topic
  10. BRCA Mutation91 topic
  11. EGFR Mutations91 topic
  12. PARP Inhibitors91 topic
  13. Genomic Profiles81 topic
  14. Small-Cell Lung Cancer81 topic
  15. AML71 topic
  16. Acute Myeloid Leukemia71 topic
  17. Apoptosis61 topic
  18. Bcl-2 Family61 topic
  19. Glioblastoma61 topic
  20. Temozolomide61 topic
  21. Chronic Lymphocytic Leukemia51 topic
  22. Genomic Aberrations51 topic

Where does Evelyn Mary McKeegan work?

Evelyn Mary McKeegan's main affiliation in the publication record is Abbott Fund, United States.

How many publications and citations does Evelyn Mary McKeegan have?

OpenAlex counts 63 works and 4,512 citations for Evelyn Mary McKeegan, an h-index of 23, ranking #1,022,319 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Evelyn Mary McKeegan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.